‘NRG-LU001: Randomized Phase II Trial of Concurrent Chemoradiotherapy +/- Metformin HCL in Locally Advanced NSCLC; ClinicalTrials.gov NCT02186847’ of page ‘NRG-LU001’
Read Press Release View Slide Presentation Principal Investigators Theodoros (Theos) Tsakiridis, MD Heath Skinner, MD, PhD Primary Objective To determine whether metformin added to chemoradiotherapy can improve progression-free survival in patients with locally advanced NSCLC Patient Population Pathologically proven diagnosis of Stage IIIA or IIIB non-small cell lung cancer; patients must have unresectable disease, be […]
Read More